A Study of HB0045 Injection in Patients With Advanced Solid Tumors

Clinical trial NCT06056323 · UNKNOWN

Trial details

NCT number: NCT06056323
Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2023-07-18
Primary completion: 2025-09-19
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.